Keyphrases
Hematopoietic Cell Transplantation
79%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
59%
Marrow Transplantation
33%
CIBMTR
32%
Confidence Interval
32%
Overall Survival
20%
Hazard Ratio
19%
Donor Type
18%
Transplantation
17%
Late Effects
17%
Myelofibrosis
17%
Myelodysplastic Syndrome
16%
Acute Myeloid Leukemia
15%
Unrelated Donor
15%
Haematopoietic Stem Cell Transplant Recipients
15%
Non-Hodgkin Lymphoma
12%
Acute Leukemia
11%
Expert Review
10%
Screening Practices
10%
Preventive Practices
10%
Metabolic Cardiovascular Syndrome
10%
Metabolic Syndrome Disease
10%
Working Party
10%
Quality of Life
10%
Pretransplant
10%
Neurocognitive Dysfunction
10%
Practice Recommendations
10%
HLA Matching
10%
Cohort Analysis
10%
American Society
10%
Chronic Myeloid Leukemia
10%
Donor Outcomes
10%
Survivors
9%
Multiple Myeloma
8%
Risk Factors
8%
Relapsed or Refractory
8%
Retrospective Analysis
7%
Myeloablative Conditioning
7%
Haploidentical
7%
Autologous Transplantation
7%
Single Center
7%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
6%
Cell Therapy
6%
European Society
6%
Acute Lymphoblastic Leukemia
6%
Induction Chemotherapy
6%
Transplant Center
6%
United States
6%
Older Adults
5%
Graft-versus-host Disease (GvHD)
5%
Medicine and Dentistry
Hematopoietic Cell
100%
Cell Transplantation
95%
Transplantation
40%
Overall Survival
18%
Late Effect
17%
Myelofibrosis
17%
Myelodysplastic Syndrome
16%
Hazard Ratio
16%
Acute Myeloid Leukemia
14%
Multiple Myeloma
13%
Non-Hodgkin Lymphoma
11%
Acute Leukemia
11%
Infection
11%
Cardiovascular Disease
10%
Lymphoma Cell
10%
Cohort Analysis
10%
Autograft
10%
Quality of Life
10%
Metabolic Syndrome
10%
Cell Therapy
10%
Disease
9%
Hodgkin's Lymphoma
8%
Scoring System
8%
Acute B-Cell Lymphoblastic Leukemia
8%
Cancer
8%
Nonmyeloablative Conditioning
7%
Adverse Event
6%
Reduced Intensity Conditioning
6%
Allograft
6%
Induction Chemotherapy
6%
Acute Lymphoblastic Leukemia
6%
Progression Free Survival
5%
Hematologic Malignancy
5%
Chimeric Antigen Receptor T-Cell Immunotherapy
5%
Cytokine Release Syndrome
5%
Hematopoietic Stem Cell Transplantation
5%
Invasive Aspergillosis
5%
Aspergillosis
5%
Ring Chromosome
5%
Classical Hodgkin Lymphoma
5%
Fluorine-18
5%
Empathy
5%
Retrospective Cohort Study
5%
Bloodstream Infection
5%
Health Care
5%
Chromosome 18
5%
Progenitor Cell
5%
Atovaquone
5%
Babesia
5%
Vancomycin Resistant Enterococcus
5%
